Bench to Bedside Pt. 2: Financial Toxicity in Patients With Hematologic Malignancies episode artwork

EPISODE · Dec 2, 2022 · 19 MIN

Bench to Bedside Pt. 2: Financial Toxicity in Patients With Hematologic Malignancies

from Hematopoiesis: An ASH Trainee Council Production · host American Society of Hematology

In the second episode of this Hematopoiesis Bench to Bedside series, Dr. Manuel Espinoza-Gutarra has conversations with Dr. Aaron Mitchell, Dr. Yousuf Zafar (@yzafar), Dr. Aju Mathew, and Dr. Nandita Khera (@khera_nandita), experts in the field of financial toxicity in cancer patients, who offer different perspectives regarding the impact of the financial costs of modern anticancer treatment puts on patients, how should we adequately measure it and how to tackle it.Music: “Somebody New” RYYZN (www.toneden.io/ryyzn/post/somebody-new-copyright-free). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/.

Episode metadata supplied by the publisher feed · Published Dec 2, 2022

Embed this episode

Ready to play

Bench to Bedside Pt. 2: Financial Toxicity in Patients With Hematologic Malignancies

0:00 19:27

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Hematopoiesis: An ASH Trainee Council Production?

This episode is 19 minutes long.

When was this Hematopoiesis: An ASH Trainee Council Production episode published?

This episode was published on December 2, 2022.

Can I download this Hematopoiesis: An ASH Trainee Council Production episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!